Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common
Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
After August 11, 2020, our common stock was trading
under the symbol “OLB” on the NASDAQ Capital Market (“NASDAQ”). Prior to August 11, 2020, our common stock was
quoted under the symbol “OLBG” on the Pink Open Market (f/k/a OTC Pink) published by OTC Markets Group, Inc. (“OTC Pink”),
where an established public trading market for our common stock did not exist.
At March 31, 2026, there were approximately 162
holders of record of our common stock, although we believe that there are other persons who are beneficial owners of our common stock
held in street name. The transfer agent and registrar for our common stock is Transfer Online, Inc., 317 SW Alder Street, 2nd Floor Portland,
OR 97204. Their telephone number is (503) 227-2950.
Dividend Policy
We have never paid any cash dividends and intend,
for the foreseeable future, to retain any future earnings for the development of our business. Our Board of Directors will determine our
future dividend policy on the basis of various factors, including our results of operations, financial condition, capital requirements
and investment opportunities.
Recent Issuance of Unregistered Securities
On June 2, 2025, Mr. Yakov converted the 1,021
shares of Series A held into 1,021,000 shares of common stock and the accrued dividends of $529,000 into 529,000 shares of common stock.
On June 2, 2025, Mr. Yakov converted $1,772,529
of principal and interest into 1,772,529 shares of common stock.
On June 2, 2025, Mr. Smith converted $69,642 of
principal and interest into 69,642 shares of common stock.
On June 2, 2025, Mr. Smith converted $510,417
and $150,000 of accrued salary and bonus, respectively, into 660,417 shares of common stock.
On June 2, 2025, Mr. Yakov converted $1,062,500
and $300,000 of accrued salary and bonus, respectively, into 1,362,500 shares of common stock.
During the year ended December 31, 2025, the Company
issued 250,000 shares of common stock for payment of $270,235 of legal fees of which $107,469 was applied to accounts payable and $162,766
has been debited to prepaid expenses.
During the year ended December 31, 2025, the Company
issued 370,000 shares of common stock for services. The shares were valued at $1.26, the closing stock price on the date of grant, for
a total value of $466,200.
During the year ending December 31, 2025, the
Company issued 35,000 shares of common stock to its CFO for services. The shares were valued at $2.02, the closing stock price on the
date of grant, for total non-cash expense of $70,700.
During the year ending December 31, 2025, the
Company issued 35,000 shares of common stock to its CFO for services. The shares were valued at $2.02, the closing stock price on the
date of grant, for total non-cash expense of $70,700.
During the year ending December 31, 2025, the
Company issued an additional 50,000 shares of common stock to its CFO for services. The shares were valued at $1.26, the closing stock
price on the date of grant, for total non-cash expense of $63,000.
Securities Authorized for Issuance Under Equity
Compensation Plans
None.
Item 6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.